Stock A006280 GC BIOPHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GC Biopharma Corp.

Equities

A006280

KR7006280002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
111,900 KRW +0.72% Intraday chart for GC Biopharma Corp. +2.57% -10.84%
Mar. 20 GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GC Biopharma Corp. Announces US FDA Approval for ALYGLO (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) CI

Evolution of the average Target Price on GC Biopharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

81.AZ6tkDAC5Xh_mhXNa9WZecLhVwB31ObkKw3fpQJ5jfE.We_e1FdbjR4S0yS4WpvWSLOXHU1anoG8YH22yzAs6rNzr9rBd0iPCDbKVA~52ba289af1e4cb07740f88af3cbdb1e2

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
111,900 KRW
Average target price
144,667 KRW
Spread / Average Target
+29.28%
High Price Target
150,000 KRW
Spread / Highest target
+34.05%
Low Price Target
140,000 KRW
Spread / Lowest Target
+25.11%

Consensus detail

Consensus revision (last 18 months)

Ratings for GC Biopharma Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A006280 Stock
  4. Consensus GC Biopharma Corp.